SMYD3 and breast carcinoma: We used two breast cancer cell lines (MCF7 and MDA-MB-231) that were previously shown to overexpress SMYD3 [8,14,18,19,20] compared with the wild type breast epithelial cell line MCF10A [18,19] (Table 1).